What top creators are saying about Medvy(MEDVY)
AI-driven telehealth company for GLP-1 medications
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Medvy in the last 30 days yet.
Top creators covering Medvy (MEDVY)
The 2 sources with the most insights about Medvy on Kazuha.
Latest insights about Medvy (MEDVY)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Monday, April 6, 2026
Facing FDA warnings for misbranding, legal action for anti-spam violations, and concerns over thin margins and non-durable marketing.
Friday, April 3, 2026
Demonstrating extreme efficiency by generating $401 million in revenue with only two employees using AI.
Monday, April 6, 2026
Facing FDA warnings for misbranding, legal action for anti-spam violations, and concerns over thin margins and non-durable marketing.
Friday, April 3, 2026
Demonstrating extreme efficiency by generating $401 million in revenue with only two employees using AI.
Discussed alongside Medvy (MEDVY)
Other assets that creators frequently mention in the same content as Medvy.
Frequently asked
Which podcasters and creators cover Medvy (MEDVY) the most?
The most active sources covering Medvy (MEDVY) on Kazuha are John Coogan & Jordi Hays, AG Dillon & Co. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Medvy (MEDVY) are on Kazuha?
Kazuha has indexed 2 AI-extracted insights about Medvy (MEDVY) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Medvy (MEDVY)?
Creators covering Medvy (MEDVY) most frequently also discuss OPENAI, ANTH, SUPABASE, STRIP, USDT. See the "Discussed alongside" section above for full asset pages.